Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 1
2019 1
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for qi jie bai
Your search for Qijie Bai retrieved no results
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Maron DJ, et al. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227755 Free PMC article. Clinical Trial.
Silencing salusin β ameliorates heart failure in aged spontaneously hypertensive rats by ROS-relative MAPK/NF-κB pathways in the paraventricular nucleus.
Li HB, Yu XJ, Bai J, Su Q, Wang ML, Huo CJ, Xia WJ, Yi QY, Liu KL, Fu LY, Zhu GQ, Qi J, Kang YM. Li HB, et al. Among authors: qi j. Int J Cardiol. 2019 Apr 1;280:142-151. doi: 10.1016/j.ijcard.2018.12.020. Epub 2018 Dec 7. Int J Cardiol. 2019. PMID: 30581101
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus JA, Jones PG, Maron DJ, O'Brien SM, Reynolds HR, Rosenberg Y, Stone GW, Harrell FE Jr, Boden WE, Weintraub WS, Baloch K, Mavromatis K, Diaz A, Gosselin G, Newman JD, Mavromichalis S, Alexander KP, Cohen DJ, Bangalore S, Hochman JS, Mark DB; ISCHEMIA Research Group. Spertus JA, et al. N Engl J Med. 2020 Apr 9;382(15):1408-1419. doi: 10.1056/NEJMoa1916370. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227753 Free PMC article. Clinical Trial.
Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats.
Huo CJ, Yu XJ, Sun YJ, Li HB, Su Q, Bai J, Li Y, Liu KL, Qi J, Zhou SW, Jia N, Zhu GQ, Liu JJ, Kang YM. Huo CJ, et al. Among authors: qi j. Toxicol Appl Pharmacol. 2020 May 1;394:114953. doi: 10.1016/j.taap.2020.114953. Epub 2020 Mar 10. Toxicol Appl Pharmacol. 2020. PMID: 32165127
PVN Blockade of p44/42 MAPK Pathway Attenuates Salt-induced Hypertension through Modulating Neurotransmitters and Attenuating Oxidative Stress.
Gao HL, Yu XJ, Liu KL, Shi XL, Qi J, Chen YM, Zhang Y, Bai J, Yi QY, Feng ZP, Chen WS, Cui W, Liu JJ, Zhu GQ, Kang YM. Gao HL, et al. Among authors: qi j. Sci Rep. 2017 Feb 22;7:43038. doi: 10.1038/srep43038. Sci Rep. 2017. PMID: 28225041 Free PMC article.
Tert-butylhydroquinone attenuates oxidative stress and inflammation in hypothalamic paraventricular nucleus in high salt-induced hypertension.
Bai J, Yu XJ, Liu KL, Wang FF, Li HB, Shi XL, Zhang Y, Huo CJ, Li X, Gao HL, Qi J, Liu JJ, Zhu GQ, Chen WS, Cui W, Kang YM. Bai J, et al. Among authors: qi j. Toxicol Lett. 2017 Nov 5;281:1-9. doi: 10.1016/j.toxlet.2017.08.018. Epub 2017 Aug 24. Toxicol Lett. 2017. PMID: 28844481
Central administration of tert-butylhydroquinone attenuates hypertension via regulating Nrf2 signaling in the hypothalamic paraventricular nucleus of hypertensive rats.
Bai J, Yu XJ, Liu KL, Wang FF, Jing GX, Li HB, Zhang Y, Huo CJ, Li X, Gao HL, Qi J, Kang YM. Bai J, et al. Among authors: qi j. Toxicol Appl Pharmacol. 2017 Oct 15;333:100-109. doi: 10.1016/j.taap.2017.08.012. Epub 2017 Aug 24. Toxicol Appl Pharmacol. 2017. PMID: 28842207
Chronic infusion of epigallocatechin-3-O-gallate into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation by restoring neurotransmitters and cytokines.
Yi QY, Li HB, Qi J, Yu XJ, Huo CJ, Li X, Bai J, Gao HL, Kou B, Liu KL, Zhang DD, Chen WS, Cui W, Zhu GQ, Shi XL, Kang YM. Yi QY, et al. Among authors: qi j. Toxicol Lett. 2016 Nov 16;262:105-113. doi: 10.1016/j.toxlet.2016.09.010. Epub 2016 Sep 19. Toxicol Lett. 2016. PMID: 27659729
Feedback